Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
-- 100 Contract Research and Contract Manufacturing Organizations will be exhibiting at this year's September 17-19, 2013 Pharma ChemOutsourcing Show at the Jersey Shore reported Apaporis LLC, the organizer. The companies offer a wide range of ...
read more
Aptuit has announced that Dr. Maurizio Denaro has assumed responsibilities as General Manager of The Aptuit Center for Discovery & Development in Verona, Italy, effective July 15, 2013.
read more
Alkermes plc today will present an overview of its proprietary pipeline portfolio at its Research and Development (R&D) Day meeting for analysts and investors. For the first time, the company will discuss three new drug candidates including: a ...
read more
OsoBio has named Lindsey Pruitt manager of new business development for its East Coast market.
read more
ResearchDx, LLC of Irvine, California today is pleased to announce the purchase, build-out and relocation to our state of the art 30,000 sq. foot facility in Irvine California. The custom designed facility will support our continued expansion of in ...
read more
As previously disclosed, Albany Molecular Research, Inc. received a warning letter, dated August 17, 2010, from the U.S. Food and Drug Administration (FDA) in connection with the FDA’s inspection of the Company’s pharmaceutical manufacturing ...
read more
IGI Laboratories, Inc., a New Jersey based generic topical pharmaceutical company, today announced it has submitted its third abbreviated new drug application (ANDA) in 2013 to the U.S. Food and Drug Administration (FDA), which brings the Company’s ...
read more
CPhI Worldwide and CPhI Pharma Evolution, part of UBM Live’s Pharmaceutical Portfolio, announce the conclusions of its first monthly report into the current status of the formulation and ingredients market- conducted amongst high level executives and...
read more
New strategic role will further enhance operational performance of all API and Formulated Product manufacturing services, focussing on industry leading product delivery across the Aesica Group
read more
With the global market for asthma and COPD drugs set to reach $47bn in 2017, inhalation drug delivery systems are gathering momentum as pharmaceutical companies develop faster acting and more effective orally inhaled products. It is crucial for ...
read more
BioWa, Inc. and Lonza today announced that they have entered into research agreements with Pfizer Inc. allowing the use of the POTELLIGENT® CHOK1SV Cell Line in the research and development of multiple proprietary antibodies in Pfizer’s pipeline.
read more
Thursday, August 01, 2013
The Society for Clinical Research Sites (SCRS) is committed in ensuring all sites can be part of the only global trade organization that provides clinical research sites a voice and a community. In nine months since its announcement, SCRS has grown ...
read more
Thursday, August 01, 2013
In June 2013, Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, hosted Otsuka America Pharmaceutical Inc.’s (OAPI) Clinical Trial Supply team at Almac’s North American Headquarters in Souderton, PA. ...
read more
Thursday, August 01, 2013
In an effort to increase the number of minority investigators in clinical research, Eli Lilly and Company and The Center for Drug Development and Clinical Trials at Roswell Park Cancer Institute (RPCI) today announced a new collaborative training ...
read more
AIT Laboratories (AIT) announces the appointment of R. Matthew Neff as President and Chief Executive Officer of the company, effective August 5, 2013. Neff will also remain in his role as Chairman of the Board for the company. Dr. Michael Evans, the...
read more